An observational study in Mesenteric Artery Ischemia, sponsored by Sahlgrenska University Hospital. Active, not recruiting at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-10.
Sponsored by Sahlgrenska University Hospital · Observational
The goal of this retrospective observational study is to describe the incidence and outcome of patients diagnosed with acute mesenteric ischemia (AMI) in the Västra Götaland region of Sweden between 2000-2023. The main questions it aims to answer are:
Participants were obtained from the regional diagnosis registry. Additional datapoints were obtained from the Swedish statistics bureau and pharmaceutical registers.
40 studies on the registry are indexed under Mesenteric Ischemia; 14 are open to participants now.
This study's enrollment of 2,446 is above the median of 154 across 26 observational studies indexed under Mesenteric Ischemia.
Browse Mesenteric Ischemia studies →Sahlgrenska University Hospital is the lead sponsor of 263 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inhabitants of the Västra Götaland region in Sweden.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
-
A cohort of all patients who were discharged with the diagnosis acute mesenteric ischemia (ICD-10: K55.0 or K55.9) in the Västra Götaland region of Sweden between 2000-01-01 and 2023-12-31.
Incidence of acute mesenteric ischemia
Annual incidence rate of acute mesenteric ischemia per 100,000 person-years in the Västra Götaland region.
Time frame: Year 2000-2023
Mortality from acute mesenteric ischemia
All-cause mortality within up to 1 year of AMI diagnosis.
Time frame: 30 days, 90 days, 1 year.
Temporal trends in incidence and mortality
Change over time in incidence and mortality, including before and after introduction of non-vitamin K antagonist oral anticoagulants (NOACs).
Time frame: Year 2000-2023
Socioeconomic determinants of incidence and outcome
Association between SES indicators (income, education, immigration status, geographic distance to care) and risk of AMI or mortality.
Time frame: Year 2000-2023
Surgical management strategy
Proportion of patients undergoing bowel resection, revascularization (open or endovascular), or non-operative management.
Time frame: Year 2000-2023
Prevalence of Short Bowel Syndrome (SBS)
Number and percentage of patients developing SBS (ICD-10 K91.2 and K90.8) after AMI.
Time frame: Within 1 year of surgical intervention
Anticoagulant use patterns
Proportion of patients using vitamin-K antagonists, NOACs, antiplatelet therapy, or no anticoagulation; association with incidence and survival.
Time frame: At AMI diagnosis; trends from 2000-2023
Plan to share: No — Individual participant data will not be shared. Due to Swedish data protection legislation and ethical restrictions, the de-identified dataset cannot be made publicly available. Only aggregated results will be published.
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital →